About: Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer. The company's first commercial product, KOMZIFTI (ziftomenib), a potent, selective, reversible and oral small molecule menin inhibitor; Darlifarnib, a Phase 1 first-in-human FIT-001 trial which includes multiple cohorts to evaluate darlifarnib in combination with other targeted therapies in large solid tumor indications; and KO-7246, a next-generation menin inhibitor, for use in diabetes and cardiometabolic disorders and additional next-generation menin inhibitors for use in combination with other therapies in solid tumors. The company is headquartered in San Diego, California.
Sector: Healthcare
Industry: Biotechnology
Latest price: $10.40 (-1.93%)
KURA NASDAQ Kura Oncology Inc
Kura Oncology Inc share price
KURA price activity
Last Price
$10.400
Change (24hr)
-0.21 USD (-1.93%)
Volume
1.21M
Volume (4w avg)
-
Open
$10.60
Day Range
$10.40 - $10.60
Previous Close
$10.60
Last Trade
12 Oct, 8:40 pm GMT+0
Delayed
12 Oct, 8:40 pm GMT+0
KURA price performance
Delayed
12 Oct, 8:40 pm GMT+0
KURA Market Signals